Home   Site Map   About Roche   Contact Us   Help   
This is a alt text for OsteoporosisThis is a alt text for Osteoporosis
Clinical. Credible. Convenient.
Main Menu
Osteoporosis Home
News
Clinical Trials
Education
Publications
Resources
Meeting Calendar

Select a link below to view details.
Previous July 2008 Next
S M T W T F S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    
Tell us what you think »
Osteoporosis Clinical Trials

Clinical Trials
 
Recruiting A randomized, open label study evaluating the effect on renal function of intravenous Bonviva given by injection or infusion, compared with oral alendronate, in postmenopausal women with osteoporosis at high risk for renal disease.
 
 
Recruiting A randomized, double-blind study to evaluate the effect of once monthly Bonviva on lumbar bone mineral density in the prevention of glucocorticoid-induced osteoporosis in post-menopausal women
 
 
Recruiting 'An open-label study of patient preference with monthly Bonviva therapy in women with post-menopausal osteoporosis switched from daily or weekly alendronate or risendronate.'
 
 
Recruiting A randomized, double-blind study of the effect of oral monthly Bonviva on in vivo bone micro-architecture parameters in post-menopausal women with osteopenia
 
 
Recruiting A randomized, double-blind study of the efficacy of intravenous Bonviva in the relief of pain after recent vertebral osteoporotic fracture in osteoporotic patients.
 
 
No longer recruiting A randomised, open label study to investigate the impact of Bone Marker Feedback at 2 months on adherence to monthly oral Bonviva (ibandronate) in women with post-menopausal osteoporosis.
 
 
No longer recruiting Randomized, open-label, multi-center study to investigate patient preference on dosing in women with postmenopausal osteoporosis treated with once monthly ibandronate and once weekly risedronate. A six month, two-sequence and two-period crossover study.
 
 
No longer recruiting A randomized, open-label study to investigate the impact of bone marker feedback on persistence to once monthly oral Bonviva (Ibandronate) treatment for post-menopausal osteoporosis.
 
 
No longer recruiting An open-label, clinical observation extension study to assess continuing safety and adherence in patients with postmenopausal osteoporosis receiving monthly oral Bonviva
 
 
No longer recruiting A randomized open-label study to investigate the impact of Bone Marker Feedback at 3 months on adherence to monthly oral Bonviva in women with post-menopausal osteoporosis supported by a patient relationship program
 
Clinical Trials Registry and Results
Roche-Trials.com » Visit Roche Trials for more information on completed Roche clinical studies.

ClinicalTrials.gov » ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers.

RocheInvestigators.com » RocheInvestigators.com: Investigators interested in applying to participate in the U.S. arm of global development clinical trials sponsored by Hoffmann-La Roche Inc., please click the link.